Company
NativeMed
NativeMed publishes compounded semaglutide at $149 a month — 3 Month Starter, sale price.
- 1 program
- 1 molecule
- 1 reading
Read from nativemed.net on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to NativeMed
We earn nothing from this link. NativeMed has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · $179 charged today · 3 Month Starter, sale price
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Product titles are "Semaglutide: Injection Home Kit" and "Tirzepatide: Injection Home Kit" and homepage describes both as "Weekly at home injection," but neither page states vial vs. pen, so form is recorded as not-disclosed rather than assumed. The semaglutide product page's pricing widget text is visually garbled by the site's variant-selector markup (duplicate "Regular price" labels); the $149/mo figure is the clearly marked sale price for the 3-month starter plan. No page states which US states are served.
Before you act
Cite this
Treatment Registry. (2026). NativeMed: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/nativemed